Sunday, 14 June 2020

Animal Genetics Market Size, Share Analysis, Strategies, Revenue And Forecasts To 2023

Market Analysis
The global animal genetics market is projected to grow exponentially at an alluring 8.4% CAGR over the predicted years (2018-2022). Animal genetics lays emphasis on the different facets of animal heredity which is the traits that passes from generation to generation. This field encompasses topics including animal breeding, genetic testing and genetic variability. Animal genetics utilizes twin techniques of general genetics, ontogenetic, mathematical-statistical, cytological, population and hybrid. On the commercial level, it is utilized for services such as genetic disease testing, DNA typing and genetic trait testing.
There are many factors that is driving the growth of the animal genetics market. Some of these factors as per the Market Research Future (MRFR) report include increasing consumption of protein that is animal-derived, rapid urbanization the world over, growing population, increasing use of advanced genetic technologies and genetic services for quality breeds and larger-scale production, rising focus to identify superior breeds, high investments in research and development activities, expansions undertaken by the leading players, rapid increase in animal diseases, increasing trend to possess companion animals, and increasing prevalence of various zoonotic diseases which boosted the demand for genetic testing. On the contrary, factors such as scarcity ok skilled experts in veterinary research, lack of technicians to conduct advanced genetic services, soaring price of animal testing, strict regulatory framework and negative effects to use genetic engineering on various animals may hinder the growth of animal genetics market.
Market Segmentation
Market Research Future report offers an all-inclusive segmental analysis of the animal genetics market on the basis of animal genetic products, services and end-user.
Based on animal genetic products, it is segmented into live animals and genetic materials. The genetic materials are further segmented into embryo and semen and the live animals are further segmented into canine, porcine, bovine, poultry and others. Of these, bovine semen is likely to have the maximum share in the market over the predicted years.
Based on services, the animal genetics market is segmented into gene trait tests, DNA typing, genetic disease tests and others. Of these, genetic disease tests will lead the market over the predicted years.
Based on end-user, it is segmented into research centers and institutes, diagnostic centers, veterinary hospitals and clinics and others.
Regional Analysis
Based on region, the animal genetics market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will sway the market over the predicted years due to growing use of animal genetics in research and rising acquisition by market players. Europe grabs the second largest position in the animal genetics market owing to high consciousness concerning the wellbeing of animals and rising investment on the region’s veterinary services. In the APAC region, the animal genetics market is expected to grow at the highest CAGR owing to increasing veterinary care services at the community level as well as the veterinary hospital. On the other hand, the animal genetics market in the Middle East and Africa will have a minimal share owing to scarcity of trained healthcare professionals and low per capita income. There however has been a boost in the demand for consistency and accuracy by the government and the end-users here that is increasing the use of the animal genetic technology.
Key Players
Key players profiled in the animal genetics market include vetGen (US), Alta Genetics (US), Animal Genetics (US), Envigo (US) Hendrix Genetics BV (The Netherland), Zoetis (US), Topigs Norsvin (Netherlands), CRV Holding B.V. (The Netherland), Groupe Grimaud (France), EW Group (Germany), URUS (US), Genus (UK), Neogen Corporation (US), and others.
Feb 2019- Wisdom Health, a popular dog genetic testing company has introduced an affordable DNA kit that works as human DNA tests. This test will not read the complete genome but will check definite number of markers. The company will compare the genetic information of a dog in their database with many other dogs. Here algorithm will be involved.
Posted by at No comments:

Global Acoustic Neuroma Market Solid Segment Analyzed By Latest Trends, Growth Rate And 2023 Insight

The global acoustic neuroma market is growing pervasively, mainly due to the rising prevalence of the condition. There are several proven, effective therapeutics and devices to treat acoustic neuroma are available in the market, which is a major factor driving the growth of the market. Indeed, technological advancements transpired in medical science and biotechnology is a key driving force behind the growth of the market, improving the outlook for the treatments.
According to a leading research firm - Market Research Future (MRFR), the global acoustic neuroma market is expected to garner massive accruals by 2023. In its recently published analysis, MRFR also asserts that the market would register a CAGR of approximately 7.6% throughout the forecast period (2017-2023).  Improving economic conditions are playing a pivotal role in the growth of the market, increasing the purchasing power of people, and access to quality healthcare.
Factors such as increasing per capita health care expenditures, governmental initiatives, spreading awareness towards the availability of novel treatment procedures to manage the condition are substantiating the growth of the market. Rising demand for new techniques for the diagnosis and advancements in surgical procedures fuel the growth of the market. 
Conversely, the high cost associated with the treatment & devices, alongside, the long approval time for the clinical trials are obstructing the growth of the market. Nevertheless, factors such as the large unmet needs especially in the developing regions would support the market growth over the assessment period, providing ample scope to the market to evolve further and prompting substantial investments for R&D to bring more novelty and betterments in the imaging techniques.
Global Acoustic Neuroma Market – Segments
The report is segmented into six market dynamics to widen the scope of understanding,
By Type                : Unilateral Vestibular Schwannomas and Bilateral Vestibular Schwannomas.
By Diagnosis      : Hearing Test (audiometry), Electronystagmography, and Magnetic Resonance Imaging (MRI), among others.
By Treatment    : Monitoring, Surgery, Radiation Therapy, and Supportive Therapy, among others.
By Drug Class     : Anticonvulsants, Corticosteroids, Osmotic Diuretics, and Pain Killers, among others.
By End-user                        : Hospitals, Diagnostic Centers, and Academic & Research Institutes, among others.
By Regions                          : Europe, North America, Asia Pacific, and the Rest-of-the-World.
Global Acoustic Neuroma Market – Geographical Analysis
North America dominates the global acoustic neuroma market with the largest market share. The presence of large numbers of notable players and diagnostic centers alongside, greater governmental emphasis on disease prevention & wellness foster the regional market growth. Moreover, substantial investments in R&D activities to develop novel therapies and breakthrough medicines drive the growth of the regional market.
Healthcare facilities in the US are gradually moving from treatments to wellness; as a result, the prevention and early detection of the disease become crucial. The US acoustic neuroma market, heading with the increasing diagnosed cases accounts for the largest share in the regional market. The rising prevalence of acoustic neuroma lifestyle fosters the market growth in the region.
The acoustic neuroma market in the European region is another lucrative market. Increasing numbers of cases alongside, the proliferation of advanced treatment facilities and availability of skilled medical professionals drive the market in the region. Moreover, the increasing government support for research & development, technological advancements, and well-spread awareness among people towards the availability of treatments for the condition support the regional market growth.
The Asia Pacific acoustic neuroma market is emerging as a rapidly growing market, globally. Factors substantiating the growth of the regional market include the increasing prevalence of acoustic neuroma, spreading awareness among people about the conditions, and the availability of new treatments to manage the condition. Growing markets in China and India contribute to the regional market growth majorly.
Global Acoustic Neuroma Market – Competitive Landscape
Fiercely competitive, the acoustic neuroma market appears to be fragmented due to the presence of many well-established players. These players, along with small players and new entrants, form a competitive edge in the market. To gain a competitive advantage in the market, these players incorporating strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product/technology launch. Substantial investments are transpired in R&D to bring innovations in the therapy and clinical trials.
Major Players:
Players leading the global acoustic neuroma market include Siemens Healthcare (US), GE Healthcare (US), Philips Healthcare (US), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), F. Hoffmann-La Roche AG (Switzerland), Novartis AG (Switzerland), Merck & Co., Inc. (US), and Pfizer Inc. (US), among others.
Industry/ Innovation/Related News:
July 22, 2019 ----- Med-El Corporation (the US), a leading global medical device company specializing in the development and manufacturing of implantable hearing solutions and speech processors announced receiving of the US FDA approval for its Cochlear Implants for single-sided deafness (SSD) and asymmetric hearing loss (AHL). Cochlear implants from MED-EL are the world’s most innovative devices helping children and adults with hearing loss hear life again. This is the first time ever that cochlear implants have been approved for these indications in the United States.
Contraindications for SSD and AHL are the same as for individuals receiving cochlear implants who have bilateral hearing loss, if the individual is known to be intolerant of the materials used in the implant and if an individual has an acoustic neuroma, and others.
Posted by at No comments:

Drug allergy Market Financial Overview, Swot Analysis, Key Development And Forecasts Till 2023

Drug Allergy Market To Grow Rapidly Reaching USD 4,764 by 2023
Market Insights
Reaction to drugs and other medication can differ from patient to patient, with drug allergies becoming increasingly common. Market Research Future (MRFR) in its latest report has discovered that the market is due to witness a CAGR of 5.1% during the forecast period of 2017 to 2023. MRFR has further ascertained that the market is expected to grow to reach an estimated value of USD 4,764 Mn by the end of 2023
Increasing awareness with regards to allergies and the growing number of new treatments and drug offerings have led to an increased demand for drug allergy diagnosis. The rising demand for drug allergy diagnosis in emerging markets where the healthcare sector is experiencing rapid growth is expected to be a major contributor to growth. Drug allergies can be caused by several factors and allergic reaction to drug combinations are one such factor which is increasingly common. New research activities are being conducted by leading market players to prevent drug allergies, as this type of allergy may ultimately impact pharmaceutical organizations negatively. This is expected to reveal market opportunities in the future.
Market Segmentation
Segmental analysis of the market in MRFR factors is performed on the basis of type,diagnosis, treatment, end-users, and region. On the basis of type, the market is segmented into immunologic and nonimmunologic. The immunologic segment is sub-segmented into type I reactions, type II reaction, type III reaction, and  others. Meanwhile, the nono-immunologic segment is further segmented into predictable, unpredictable, and others. The predictable subsegment is even further segmented to include pharmacologic side effects, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose and others.
By diagnosis, the market is segmented into skin test, blood test, patch test, and others. Skin test can be done by prick or scratch test,  intradermal test, and others.
By treatment, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of drug and others. Antihistamines are categorized by Levocabastine Eyedrops, Levocabastine Oral, Azelastine Nasal Sprays, Hydroxyzine, Azelastine Eyedrops, Cyproheptadine, Carbinoxamine, Emedastine Eyedrops, Diphenhydramine, Desloratadine, and others. Other sub-segmentations regarding corticosteroids are included in MRFR's report.
Regional Analysis
Globally, the drug allergy market is divided into the Americas, Europe, the Asia Pacific, and the Middle East & Africa. The Americas, led by North America, lead the market with the largest share. The U.S is one of the highest revenue generating countries in the region and is a key market for drug allergies. It has been found that close to 10% of the U.S population is affected by drug allergies. The presence of several important market players and high consumption of pharmaceutical drugs has increased the number of patients who have drug allergies. The Latin American market is growing swiftly due to improving health care and the high demand for treatment and diagnosis of drug allergies among emerging markets of the region.
The Asia-Pacific is growing at the swiftest pace and is expected to display the highest CAGR during the forecast period. Japan holds the largest share of the APAC market while China displays the fastest growth potential and the highest CAGR during the forecast period. Growing awareness regarding drug allergies and the growing demand for pharmaceuticals has led to an increased demand for diagnosis and treatment of drug allergies in the region. Patients are increasingly becoming involved in health care, and the rapidly changing healthcare practices that this region is experiencing is expected to expand the market significantly in the foreseeable future.
Key Players
Eminent market players that have been analyzed in the competitive analysis included in MRFR's report are Bayer, AstraZeneca, Circassia, HAL Allergy Group, Johnson & Johnson Services Inc., Stallergenes Greer, MAGNA Pharmaceuticals Inc, and others.
Latest Industry News
  • Epipens are facing a supply crunch across the globe due to manufacturing problems faced by Pfizer. This has resulted in rationing the access to this vital medicine for anaphylactic
  • In other related news, the U.S FDA has recognized the shortage and provided Teva Pharmaceuticals with approval for a generic version of the EpiPen in both 0.3mg and 0.15mg strength.
Posted by at No comments:

Worldwide Anti-viral drugs Market 2019 Synopsis With Leading Players, Industry Growth Factor Foresight By 2023

Market Highlights
Anti-viral drugs are used to treat viral infections and are the only agents acting against viruses as either other drugs are ineffective or too toxic. The market segment of anti-viral drugs is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO has estimated that in 2015 about 36.7 million people are suffering from HIV/AIDS with 1.1 million deaths occurring due to AIDS-related illness the emergence of donor funding in the treatment of the disease has also increased the demands of anti-viral drug market. Strong research pipeline coupled with rise in research and development investment will be the market driver of the future.
The constraints on the market include side effects associated with treatment, the cost of the therapy and poor efficacy and effectiveness of the drugs.
Key Players for Global Anti-Viral Drugs Market:Some of the key players in this market are: Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Abbott Laboratories, Novartis International AG, Astra Zeneca AB, Cipla Inc.
Market Segments:Global Anti-viral drugs market has been segmented on the basis of application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.
Regional Analysis of Global Anti-Viral Drugs Market:
Globally America is the largest market for anti-viral drugs. North America dominated the market for anti-viral drugs with a share of greater than 30%.  Europe is the second-largest market for anti-viral drugs. Asia pacific region is expected to be fastest growing region in anti-viral drugs market.
The report for Global Anti-Viral Drugs Market of Market Research Future comprises extensive primary research along with the detail analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Posted by at No comments:

Bioinformatics Market Key Manufactures Shares, Analysis And Forecasts Till 2023

The global bioinformatics market is expected to exhibit a CAGR of 19.8% over the forecast period from
2016 to 2022, according to a new research report from Market Research Future (MRFR). The global
bioinformatics market is mainly driven by the growing demand in developing countries in enhancing
their healthcare sector and making advanced healthcare modalities available to patients.
The growing demand for electronic healthcare data storage is likely to be a major driver for the global
bioinformatics market. The reliance on manual and paper-based documentation of healthcare
procedures has resulted in unmanageable volumes of healthcare information, which can make it difficult
to locate individual patients and their medical history. Electronic healthcare records, which are but the
first step of the bioinformatics market, have already become widely popular in developed countries due
to the benefits they present in terms of consistent data storage over the long term and ease in acquiring
specific details at any given time. The growing demand for e-prescriptions and online pharmacies is
likely to further the cause of the bioinformatics market over the forecast period, as strong
bioinformatics networks are needed to operate and manage e-prescriptions and the related
documentation.
Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/2265

The growing demand for strong data storage facilities in medical research is also likely to be a major
driver for the global bioinformatics market. Bioinformatics plays a key role in genetic studies, in which it
helps track details regarding multiple genes and their multifarious associations with the indicators being
studied in the respective trial. The growing dependence on genetic studies in cancer research is likely to
be a major driver for the global bioinformatics market over the forecast period, as cancer research has
received strong government backing across the world. Other medical research applications are also
likely to make use of bioinformatics systems on a large scale in the coming years, leading to steady
growth of the global bioinformatics market over the forecast period.
Competitive Analysis:
Leading players in the global bioinformatics market include Agilent Technologies, Qiagen N.V., Dassault
Systemes, Thermo Fisher Scientific Inc., and Illumina Inc.
Segmentation:
The global bioinformatics market is segmented on the basis of application, service, sector, and region in
the MRFR report in order to provide a comprehensive coverage of all important factors related to the
market’s growth prospects over the forecast period.
The bioinformatics market has been segmented on the basis of application into genomics,
chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics,
DNA sequences, and others. Increasing interest in genetic studies is likely to be a major driver for the
global bioinformatics market over the forecast period.
On the basis of services and technology, the global bioinformatics market is segmented into data
warehousing, sequence analysis, sequence manipulation, and others.
On the basis of sector, the bioinformatics market is segmented into medical bioinformatics, animal
bioinformatics, agriculture bioinformatics, and others. Medical bioinformatics is likely to dominate the
global bioinformatics market over the forecast period due to the increasing government support for the
use of bioinformatics modalities in clinical decision making and research.
Regional Analysis:
The global bioinformatics market is segmented by region into the Americas, Europe, Asia Pacific, and the
Middle East and Africa. The global bioinformatics market is dominated by the Americas and Europe in
terms of region due to the presence of strong telecommunications infrastructure in these regions to
support advanced bioinformatics processes. The presence of a strong wireless internet and other
telecommunication features is crucial for a bioinformatics system to function productively. This has
actually been one of the key factors that has held back the bioinformatics market in underdeveloped
regions.
In April 2019, researchers from UCLA announced a plan to develop a system that would allow scientists
in developing countries to use cloud computing and big data analytics to accelerate the development of
the bioinformatics field in their own countries. Efforts such as these are the result of the growing
awareness of the disparity in terms of telecommunications infrastructure between developed and
developing countries.
Asia Pacific is likely to exhibit the fastest growth over the forecast period due to the increasing efforts
from governments in the region to incorporate powerful bioinformatics programs into the day-to-day
functioning of their country’s healthcare sector.
Posted by at No comments:

Worldwide Medical Tricorder Market Booming Industry Size And Revenue | Future Vision Footbridge 2023 In Healthcare Sector


Market Synopsis of Global Medical Tricorder Market
Medical device used by the consumer to self-diagnose medical condition is known as a medical tricorder. It takes basic vital measurement like heart rate and body temperature within seconds. Major functions of a medical tricorder are to monitor health of a person, summarize patient’s health, diagnose disease and take health measurements. Furthermore, rapid development in technology, increasing government support for research & development, changing lifestyle, and many adverse effects of the present diagnostic methods expected to fuel the market growth during the forecast period.
Medical Device Industry is flourishing across the globe owing to an increasing demand for technologically advanced devices, extensive use of smart medical devices, and overall improvement in healthcare sector. Various smart devices are used to determine the heart rate, glucose levels in the body, and other parameters.
Global medical tricorder market is expected to reach USD 5.4 billion in 2023 from USD 2.5 billion in 2016 with a CAGR of approximately 6.7% during the forecast period 2017-2023.
However, these types of devices has to pass all the regulatory standards and rules, which increases the approval time. The average approval time for the medical diagnostic device may vary from 5-8 years. This long approval time, high cost of the research & development and devices may hamper the market growth during the corresponding period.
The demand of medical tricorder is increasing because of an increase in the demand medical tricorder among health care providers, helping them to diagnose patient’s health condition, increasing outpatient services in the hospitals, increase in patient pool suffering from diabetes, and cardiovascular diseases, and demand for new technology for diagnoses and monitoring.
According to findings from the WHO, in 2014, approximately 422 million people suffered from diabetes across the globe.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/1220  
Global Medical Tricorder Market – Regional:
Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.
America is the largest market which is attributed to extensive use of medical tricorder by number of physicians in America. Increasing in patient pool, increase in outpatient services and concentration of major market players of medical tricorder in North America drive this market in America. North America is the largest market whose growth is attributed to an increase in patient pool, and demand for improved technology for diagnosis of ongoing health of a patient drive this market in America. According to the American Diabetes Association, in 2015, approximately 30.3 million Americans which is 9.4% of the American population were suffering from diabetes 
The European market is also growing continuously and slowly catching up with the American market in the near future. Emphasis for early diagnosis of disease condition and awareness regarding the use of tricorder. Extensive research in innovative product development, and adoption of new technologies in healthcare institutes such as hospitals & clinics, research institutes, clinical laboratories, diagnostics center and home care settings. QuantuMDx Group Ltd. is in Europe. It is one of the major market players for medical tricorder, thus favoring the opportunities for research and development activities in the field of medical devices and molecular diagnosis.
Asia-Pacific market is expected to show steady growth in the medical tricorder market during the forecasted period owing to the rising prevalence of chronic diseases such as obesity, diabetes, cardiovascular diseases, growing geriatric population, and development in healthcare sector. China and India are expected to be the emerging market in Asia Pacific, owing to the increasing number of patients diagnosed with chronic diseases, and high growth potentials supported by favourable macro-economic conditions.
Middle East & Africa show slow growth in this market owing to demand for primary care services for the diagnosis and treatment of chronic diseases, and rising awareness about preventive measures for various diseases, and increasing emphasis on women and child care.
Global Medical Tricorder Market: Company Analysis
Ibis Biosciences, Inc. provides molecular diagnostics, offers instruments and reagents to analyze DNA and RNA for clinical specialists and laboratory. In February 2016, the company won a USD 2,124,718 federal contract from the Defense Advanced Research Projects Agency, Arlington, Virginia for R&D.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/medical-tricorder-market-1220

Posted by at No comments:

Global Bone Density Test Market Outlook, Key Financials, Segmental Revenue And Geographical Revenue Till 2023

Recognizing the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the years to come. Recent technological advancements and bone density test market trends have boosted the Bone Density Test market growth, increasing the uptake of bone density test.  Besides, increasing prevalence of osteoporosis, osteopenia, hyperthyroidism, and increasing demand for portable bone testing devices foster the market growth.  Moreover, the demand for diagnosis and treatment measures for osteoporosis escalates the market growth of the bone density test on the global platform.
Market Research Future (MRFR), in its recently published market forecast asserts that the global bone density test market will grow exponentially by 2023, registering approximately 7.2% CAGR during the review period (2017 – 2023).
Additional factors substantiating the market growth include the demand for technologically advanced devices and growing geriatric populace.  Also, substantial technological strides being made in electronic monitoring devices and substantial investments transpired into R&D activities are in turn, paying off well, expanding the market size.
Bone density test provides more of a high-level overview and in-depth details on more specific aspects of bone health alongside indicating current and potential health risks such as Low bone mineral density, Osteoporosis, and Hyperthyroidism.  A stress fracture or other bone issue is often the initial reason that can cause impaired bone health and can affect bone density in the future. All these factors indicate that a bone is not as strong as normal bone and places that are at risk for stress fractures or other broken bones.
Furthermore, the ever-increasing population that is increasingly adopting the sedentary lifestyle and urbanization are supporting the market growth. Improving economic conditions are providing impetus to the market growth, increasing the healthcare expenditures and availing rapid access to the excellent health care.
On the other hand, limited or no awareness of the advantages of bone density test is impeding the market growth.  Also, the unmet clinical needs coupled with the unavailability of external funding are acting as a headwind to the market growth, especially in the developing regions. Nevertheless, increasing demand for portable and hand-held diagnostic devices alongside the augmenting demand for the bone density test in the diagnostics to obtain fastest & accurate results is expected to fuel the market growth. 
Competitive Analysis
The market for bone density test appears fragmented and fiercely competitive due to many large and small players churning the competition in the market.  Through the strategic partnership, acquisition, expansion, product & technology launch, and collaboration, these players try to gain the competitive edge.
The global bone density test market is led by some of the fervent players like
  • Hologic Inc. (U.S),
  • General Electric Company (U.S.),
  • BeamMed Ltd.  (Israel),
  • Osteosys Corp (South Korea),
  • Swissray (U.S.),
  • DMS Imaging (France),
  • Osteometer Meditech Inc. (U.S),
  • Medonica Co. LLTb (South Korea),
  • Lone Oak Medical Technologies, LLC (U.S.).
Global Bone Density Test Market – Segments
The market can be segmented into five key dynamics for the convenience of understanding;
By Types                   : Central Dual-Energy X-Ray Absorptiometry (DXA), Peripheral Tests {peripheral dual-energy X-ray absorptiometry (pDXA), quantitative ultrasound (QUS), peripheral quantitative computed tomography (pQCT), others} and Radiographic Absorptiometry among others.

By Indications    : Osteoporosis, and Hyperthyroidism, others.
By Devices               : Central DEXA Scan Machine and others.
By End-Users          :  Hospitals, clinics, and diagnostic centers, among others.
By Regions              :  North America, Europe, APAC and the Rest-of-the-World (RoW).
Regional Analysis
The North American region is estimated to retain its dominance over the global bone density test market with the largest market share. A well-developed healthcare sector, increasing prevalence of diseases and disorders related to bones such as osteoporosis, osteopenia, and hyperthyroidism along with the high per capita healthcare expenditures drive the market growth in the region. The region is expected to create a substantial revenue pocket registering a strong CAGR throughout the forecast period (2017-2023). Furthermore, the presence of prominent market players especially in the U.S. & Canada impacts the market growth positively. 
The European region accounts for the second-largest market for bone density test, emerging as another lucrative market, globally. The U.K., backed by its sizeable vast bone density test market and Germany with its vast medical device industry is expected to drive the market growth in the region. Favorable governmental support and initiatives drive the growth in the market extensively. The proliferating healthcare sector in the region, backed by the resurging economy is fostering the market growth radiantly.
The Asia Pacific region is emerging as a promising market for bone density test owing to the rising prevalence of osteoporosis in women after menopause. Furthermore, increasing awareness towards women healthcare and nutrition influences the market growth. Changing lifestyle and overall development of medical device industry supports the growth of the market in the region.  Besides, the increasing healthcare expenditures and favorable government policies of developing economies like India and China substantiate the market growth in the APAC region.
Browse more details of Bone Density Test Market @ https://www.marketresearchfuture.com/reports/bone-density-test-market-4766
Posted by at No comments:
Subscribe to: Posts (Atom)